Our results lend support to the hypothesis that serum omentin may comprise a prognostic biomarker of stroke severity in the early phase of ACI, as indicated by the independent positive association between serum omentin concentrations and neurological impairment on admission after adjustment for potential confounders. The gene discussed is ITLN1; the disease is stroke disorder.